Singapore markets close in 3 hours 26 minutes

UG Healthcare Corporation Limited (8K7.SI)

SES - SES Delayed price. Currency in SGD
Add to watchlist
0.1110-0.0010 (-0.89%)
As of 09:00AM SGT. Market open.
Currency in SGD

Valuation measures4

Market cap (intra-day) 69.87M
Enterprise value 53.20M
Trailing P/E 9.53
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.74
Price/book (mrq)0.41
Enterprise value/revenue 0.56
Enterprise value/EBITDA -2.61

Trading information

Stock price history

Beta (5Y monthly) 0.76
52-week change 3-30.00%
S&P500 52-week change 321.08%
52-week high 30.2250
52-week low 30.0860
50-day moving average 30.1169
200-day moving average 30.1199

Share statistics

Avg vol (3-month) 31.06M
Avg vol (10-day) 3337.46k
Shares outstanding 5623.83M
Implied shares outstanding 6623.83M
Float 8187.39M
% held by insiders 171.08%
% held by institutions 10.03%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 43.23%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.34
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 417 Nov 2022
Last split factor 23:1
Last split date 330 Sept 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -22.05%
Operating margin (ttm)-12.22%

Management effectiveness

Return on assets (ttm)-6.28%
Return on equity (ttm)-12.43%

Income statement

Revenue (ttm)94.93M
Revenue per share (ttm)0.15
Quarterly revenue growth (yoy)-11.10%
Gross profit (ttm)N/A
EBITDA -20.88M
Net income avi to common (ttm)-20.93M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)45.13M
Total cash per share (mrq)0.07
Total debt (mrq)28.46M
Total debt/equity (mrq)16.61%
Current ratio (mrq)5.28
Book value per share (mrq)0.28

Cash flow statement

Operating cash flow (ttm)-37M
Levered free cash flow (ttm)-15.5M